Collegium Pharmaceutical
COLL
COLL
159 hedge funds and large institutions have $668M invested in Collegium Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $719M → $668M (-$51M)
12% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 57
Holders
159
Holding in Top 10
–
Calls
$18K
Puts
$1K
Top Buyers
| 1 | +$4.64M | |
| 2 | +$4.01M | |
| 3 | +$3.01M | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$2.93M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$2.88M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$6.06M | |
| 3 | -$3.74M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.27M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.4M |